TANDEM DIABETES CARE INC (TNDM) › Capital ExpendituresTANDEM DIABETES CARE INC (TNDM) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2012: $4.53M2013: $4.01M2014: $4.41M2015: $5.76M2016: $8.93M2017: $5.72M2018: $2.99M2019: $19.54M2020: $27.41M2021: $14.18M2022: $34.10M2023: $26.80M2024: $19.23M2025: $19.95M$19.95M2012Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$19.95M+3.7%2024$19.23M-28.3%2023$26.80M-21.4%2022$34.10M+140.5%2021$14.18M-48.3%2020$27.41M+40.3%2019$19.54M+554.4%2018$2.99M-47.8%2017$5.72M-36.0%2016$8.93M+54.9%2015$5.76M+30.8%2014$4.41M+9.9%2013$4.01M-11.5%2012$4.53M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share